| 1 | [SID103162789] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID103162789] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID103162789] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID103162789] | Active | AbsAC26_uM | 0.657 | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity [AID624491, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | AbsAC26_uM | 0.657 [uM] | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624491 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID103162789] | Active | Potency | 0.7308 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID103162789] | Active | Potency | 0.7308 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID103162789] | Active | Potency | 0.7308 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID103162789] | Active | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 9 | [SID103162789] | Active | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 10 | [SID103162789] | Active | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID103162789] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 12 | [SID103162789] | Active | | | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652134, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652134 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 13 | [SID103162789] | Inactive | IC50 | 67.433 | Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID687017, Type: confirmatory] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | IC50 | 67.433 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 687017 | | BioAssay type | confirmatory | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 14 | [SID103162789] | Inactive | IC50 | 67.433 | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID687018, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | IC50 | 67.433 [uM] | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 687018 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 15 | [SID103162789] | Inactive | IC50 | 67.433 | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID687018, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | IC50 | 67.433 [uM] | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 687018 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 16 | [SID103162789] | Inactive | IC50 | 67.433 | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID687018, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | IC50 | 67.433 [uM] | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 687018 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 17 | [SID103162789] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 18 | [SID103162789] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 19 | [SID103162789] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 20 | [SID103162789] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 21 | [SID103162789] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 22 | [SID103162789] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 23 | [SID103162789] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 24 | [SID103162789] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|
| 25 | [SID103162789] | Inactive | | | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity [AID602481, Type: screening] | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602481 | | BioAssay type | screening | | Target | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] | | PubMed | | | Data Table |  |
|
| 26 | [SID103162789] | Inactive | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 27 | [SID103162789] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID103162789] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID103162789] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 30 | [SID103162789] | Inactive | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 31 | [SID103162789] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 32 | [SID103162789] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 33 | [SID103162789] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 34 | [SID103162789] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 35 | [SID103162789] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 36 | [SID103162789] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 37 | [SID103162789] | Inactive | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 38 | [SID103162789] | Inactive | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 39 | [SID103162789] | Inactive | | | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay [AID651699, Type: screening] | NAE1 gene product [Homo sapiens] [gi:4502169] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay | | AID | 651699 | | BioAssay type | screening | | Target | NAE1 gene product [Homo sapiens] [gi:4502169] | | PubMed | | | Data Table |  |
|
| 40 | [SID103162789] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] | | PubMed | | | Data Table |  |
|
| 41 | [SID103162789] | Inactive | | | uHTS identification of small molecule activators of alpha dystroglycan glycosylation [AID624168, Type: screening] | LARGE [Homo sapiens] [gi:47678551] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule activators of alpha dystroglycan glycosylation | | AID | 624168 | | BioAssay type | screening | | Target | LARGE [Homo sapiens] [gi:47678551] | | PubMed | | | Data Table |  |
|
| 42 | [SID103162789] | Inactive | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 43 | [SID103162789] | Inactive | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 44 | [SID103162789] | Inactive | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 45 | [SID103162789] | Inactive | | | Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set [AID602162, Type: screening] | ABCB6 gene product [Homo sapiens] [gi:9955963] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set | | AID | 602162 | | BioAssay type | screening | | Target | ABCB6 gene product [Homo sapiens] [gi:9955963] | | PubMed | | | Data Table |  |
|
| 46 | [SID103162789] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity [AID651711, Type: screening] | Protein disulfide-isomerase A6 [gi:2501205] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651711 | | BioAssay type | screening | | Target | Protein disulfide-isomerase A6 [gi:2501205] | | PubMed | | | Data Table |  |
|
| 47 | [SID103162789] | Inactive | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 48 | [SID103162789] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 49 | [SID103162789] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 50 | [SID103162789] | Inactive | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103162789 | | CID | 49795289 | | Outcome | Inactive | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|